5/10/2022 | BlogPost
It's been a pleasure catching up with Jessica DaMassa on the latest digital health news and updates.
We picked up from where we left off from our last chat regarding the digital transformation of healthcare during the pandemic.
First, I provided an update on Telehealth adoption trends.
Given that physical access is largely restored, what's very interesting is that the collective proof of concept for using Telehealth remains stable, so physicians are becoming more comfortable with it and have begun rethinking workflows, integrating these remote access options.
Then, of course, we explored digital medicine and digital therapeutics recognition across Europe.
As a result of the COVID acceleration, Telehealth has gained a lot of traction. At the same time, Digital Medicine and Digital Therapeutics are also being recognized, even though they have not yet been developed and adopted at the same level as Telehealth. Patient awareness of this evolving scenario is now essential, as well as filling the gap in medical education.
We also discussed the current digital health funding scenario, where there are still great deals, although not as many as in the past two years.
Evaluations are also getting smaller, and the market is becoming more selective. A greater emphasis is placed on clinical evidence, early traction, and the science behind certain kinds of solutions. And certainly, there is an extended focus on unmet patient needs.
Furthermore, we gave a sneak peek into the Frontiers Health 2022 Conference, where we will share the stage as co-masters of ceremony.
As for what is new for this edition, we have a longer networking lunch and a two-hour aperitivo at the end of the day. The first day will be a full plenary structure, while the second day will be all about breakouts, with more than 600 attendees in presence in Milan and on-line.
We will cover Digital Therapeutics, Clinical Trial Efficiency, Path to Market, Scalability, Global Market Access and much more, including ways to make health care affordable and accessible globally. Additionally, we will welcome over 100 investors and 150 startups, 30 of which will be on stage presenting their solutions.
One of the highlights of this year's conference will be a track called Frontiers Health Science that will explore the intersection of biology and advanced digital technology (ex. AI in drug design and discovery, advanced physics combined with data).